Report Details:
15 Companies Covered
104 Pages
Pune, India, July, 2025/MRFR Press Release/- Market Research Future has a half cooked research report on the global Hammertoe market.
Market Highlights
The Hammertoe Market is expected to reach USD 2.9 billion by 2032 at 12.32% CAGR during the forecast period 2024-2032
Hammertoe is a foot deformity due to an imbalance in the muscles, tendons or ligaments which normally hold the toe straight. A hammertoe has an abnormal bend in the middle joint of a toe and usually occur in your second, third and fourth toes. The causes of hammertoe are wrong type of shoes such as excessively high heels or shoes that are too short or narrow that force the toe into a bent position, foot structure such as bunions or other foot problems, trauma and certain muscle, nerve, or joint damage diseases such as osteoarthritis, rheumatoid arthritis, stroke, Charcot–Marie–Tooth disease, complex regional pain syndrome or diabetes. Changing your footwear and wearing shoe inserts may relieve the pain and pressure of hammertoe but severe cases require surgery to get relief.
The treatment in most cases consists of physical therapy and new shoes with soft, spacious toe boxes and surgery in severe cases of hammertoe. In some cases a brace that pushes down on the toes to force them to stretch out their muscles is also prescribed. Hammertoe affects approximately 500,000 people in the US alone.
Product development and development of novel implants and orthopedic devices is the most attractive strategy for the Hammertoe industry. Majority of these hammertoes are treated with wire pins also called K-wires, but are associated with inconveniences such as movement limitations and shoewear and dislodgement of the wires. Advances in implant design have made hammertoe implants, a feasible surgical option which permanently remains within the toe bone.
Global Hammertoe Market Players
Key players profiled in the report are BioPro, Instratek, Stryker Corporation, Extremity Medical LLC, Arrowhead Medical Device Technologies, LLC, Wright Medical Group, Inc., Nextremity Solutions, LLC, Smith & Nephew plc., Biomet, Inc., Acumed and others.
Regional Analysis
The global Hammertoe market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.
The Americas dominate this market, particularly North America due to high healthcare expenditure in the region.
Rising screening are major drivers for the growth of Europe Hammertoe market. Some other factors such as growing number cases, advanced healthcare facilities, and adoption of new implants are driving the growth for the market.
Asia Pacific is the fastest growing and high potential market for Hammertoe. This growth is majorly attributed to developing healthcare sector, changing healthcare practices, growing number of cases and rising demand from the countries like China.
The Middle East & Africa region is expected to have limited growth due to some factors such as traditional healthcare practices, limited access and availability of the products, poor public healthcare expenditure etc.
Segmentation
The global Hammertoe market has been segmented on the basis of type, diagnosis, treatment and end users.
Based on type, the market has been segmented as flexible hammer toes and rigid hammer toes.
Based on the diagnosis, the market has been segmented into physical exam, X-rays and others.
Based on the treatment, the market has been segmented into drugs, orthotic devices, surgery and others.
Based on the end users, the market has been segmented as hospitals & clinics, physiotherapy and orthopedic centers and others.